Adherence to evidence-based treatments for reduced ejection fraction heart failure across age strata: a nationwide cohort study

被引：0
|
作者：
Stolfo, Davide [1 ,2 ]
Schrage, Benedikt [2 ]
Lund, Lars H. [2 ]
Sinagra, Gianfranco [1 ]
Savarese, Gianluigi [2 ]
机构：
[1] Asugi, SC Cardiol, Trieste, Italy
[2] Karolinska Inst, Div Cardiol, Dept Med, Stockholm, Sweden
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2020年 / 22卷 / 0N期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
611
引用
收藏
页码：N101 / N101
页数：1
相关论文
共 50 条
  • [21] Evidence-based heart failure treatment effect on mortality despite ejection fraction
    Tamariz, Leo
    Palacio, Ana
    Lopez, Barbara
    Arcement, Lee
    Macedo, Francisco Igor
    Macedo, Fancisco Yuri
    Hebert, Kathy
    [J]. CIRCULATION, 2008, 117 (21) : E426 - E426
  • [22] Optimization of evidence-based therapies for heart failure and reduced ejection fraction improves outcomes in an ambulatory specialized setting
    Jarjour, M.
    Henri, C.
    Fortier, A.
    O'meara, E.
    De Denus, S.
    Bouabdallaoui, N.
    Racine, N.
    White, M.
    Rouleau, J. L.
    Ducharme, A.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 235 - 235
  • [23] Significance of ischemic heart disease in patients with heart failure with preserved, mid-range and reduced ejection fraction - A nationwide cohort study
    Vedin, O. Ola
    Lam, C. S. P.
    Koh, A. S.
    Benson, L.
    Teng, T. H. K.
    Tay, W. T.
    Braun, O. O.
    Savarese, G.
    Dahlstrom, U.
    Lund, L. H.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 347 - 347
  • [24] SUDDEN CARDIAC DEATH IN HEART FAILURE WITH PRESERVED EJECTION AS COMPARED TO HEART FAILURE WITH REDUCED EJECTION FRACTION: A NATIONWIDE ANALYSIS
    Aguilar, Rodrigo
    Vilchez, Daniel
    Mansoor, Kanaan
    Suliman, Mohamed
    Picon, Maria
    Rios, Carlos Rueda
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 868 - 868
  • [25] Safety of midodrine in patients with heart failure with reduced ejection fraction: a retrospective cohort study
    Wu, Ming-Ju
    Chen, Cheng-Hsu
    Tsai, Shang-Feng
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [26] Heart Failure With Preserved Ejection Fraction is Associated With Lower In-hospital Mortality Compared to Heart Failure With Reduced Ejection Fraction: A Nationwide Analysis
    Yue, Bing
    Krittanawong, Chayakrit
    Fang, Shuyang
    Wei, Xin
    Khandaker, Mariam
    Weiss, Allen
    Herzog, Eyal
    [J]. CIRCULATION, 2017, 136
  • [27] Guideline-directed medical therapy for heart failure does not exist: a non-judgmental framework for describing the level of adherence to evidence-based drug treatments for patients with a reduced ejection fraction
    Packer, Milton
    Metra, Marco
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (10) : 1759 - 1767
  • [28] The safety and tolerability of beta blockers in heart failure with reduced ejection fraction: is the current underutilization of this evidence-based therapy justified?
    Kiel, Richard. G.
    Deedwania, Prakash
    [J]. EXPERT OPINION ON DRUG SAFETY, 2015, 14 (12) : 1855 - 1863
  • [29] Impact of the duration of the evidence-based medicine use in acute heart failure: A nationwide cohort study
    Wu, Wei-Tsung
    Chu, Chun-Yuan
    Hsu, Po-Chao
    Lee, Wen-Hsien
    Su, Ho-Ming
    Yen, Hsueh-Wei
    Voon, Wen-Chol
    Lai, Wen-Ter
    Sheu, Sheng-Hsiung
    Lin, Tsung-Hsien
    [J]. PLOS ONE, 2018, 13 (10):
  • [30] How to Manage Heart Failure Patients with Not Reduced Ejection Fraction Based on Available Evidence?
    Ural, Dilek
    [J]. TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2022, 50 (04): : 237 - 238
12345